ProRx LLC recalls TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02
Recalled September 11, 2024 · FDA recall D-0656-2024 · ProRx
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
1,732 vials
Sold at
Nationwide in the USA
Description
Lack of Assurance of Sterility
Product
TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02
Manufacturer(s)
ProRx LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →